allAfrica.com on MSN
Encouraging Results from a First-in-Human Phase 1 Clinical Trial of IAVI's Lassa Vaccine Candidate Published in New England Journal of Medicine
Findings are consistent with previous studies of a similarly constructed licensed Ebolavirus vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback